Complement C5a receptor-mediated signaling may be involved in neurodegeneration in Alzheimer's disease

Journal of Immunology

Volumn 170, Issue 11, 2003, Pages 5764-5771

  Farkas, Imre ^a,e   Takahashi, Mitsuo ^b,c   Fukuda, Atsuo ^d   Yamamoto, Naoki ^a   Akatsu, Hiroyasu ^b   Baranyi, Lajos ^b,f   Tateyama, Hisashi ^a   Yamamoto, Takayuki ^b   Okada, Noriko ^a   Okada, Hidechika ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^f WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT COMPONENT C5A RECEPTOR ANTIBODY; MONOCLONAL ANTIBODY; PEPTIDE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CALCIUM METABOLISM; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL CULTURE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; GRANULAR CELL; HIPPOCAMPUS; HOMEOBOX; MOUSE; MULTIINFARCT DEMENTIA; NERVE DEGENERATION; NEUROBLASTOMA CELL; NEUROPATHOLOGY; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PYRAMIDAL NERVE CELL; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION; STAINING;

EID: 0037851003     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.11.5764     Document Type: Article

References (43)

1. McGeer, E. G., and P. L. McGeer. 1998. The importance of inflammatory mechanisms in Alzheimer disease. Exp. Gerontol. 33:371.
2. Neuroinflammation Working Group. 2000. Inflammation and Alzheimer's disease. Neurobiol. Aging 21:383.
3. Shen, Y., L.-F. Lue, L.-B. Yang, A. Roher, Y.-M. Kuo, R. Strohmeyer, W. J. Goux, V. M. Lee, G. V. W. Johnson, S. Webster, et al. 2001. Complement activation by neurofibrillary tangles in Alzheimer's disease. Neurosci. Lett. 305:165.
4. Rogers, J., N. R. Cooper, S. Webster, J. Schulz, P. L. McGeer, S. D. Styren, W. H. Civin, L. Brachova, B. Bradt, P. Ward, and I. Lieberburg. 1992. Complement activation by β-amyloid in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 89:10016.
5. Shen, Y., R. Li, E. G. McGeer, and P. L. McGeer. 1997. Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain. Brain Res. 769:391.
6. Terai, K., D. G. Walker, E. G. McGeer, and P. L. McGeer. 1997. Neurons express proteins of the classical pathway in Alzheimer disease. Brain Res. 769:385.
7. Bradt, B., W. P. Kolb, and N. R. Cooper. 1998. Complement-dependent proinflammatory properties of the Alzheimer's disease β-peptide. J. Exp. Med. 188:431.
8. Strohmeyer, R., Y. Shen, and J. Rogers. 2000. Detection of complement alternative pathway mRNA and proteins in the Alzheimer's disease brain. Mol. Brain Res. 81:7.
9. Webster, S., L.-F. Lue, L. Brachova, A. J. Tenner, P. L. McGeer, K. Terai, D. G. Walker, B. Bradt, N. R. Cooper, and J. Rogers. 1997. Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease. Neurobiol. Aging 18:415.
10. Rother, K., G. O. Till, and G. M. Hansch. 1998. The Complement System, 2nd Ed. Springer-Verlag, New York.
11. Takahashi, M., L. Baranyi, C. Sakurada, T. Yamamoto, N. Okada, and H. Okada. 1995. Expression of C5a receptor in the central nervous system. In Proceeding of the Complement System, Vol. 32, p. 65 (in Japanese).
12. Gasque, P., P. Chan, M. Fontaine, A. Ischenko, M. Lamacz, O. Gotze, and B. P. Morgan. 1995. Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. J. Immunol. 155:4882.
13. Gasque, P., S. K. Singhrao, J. W. Neal, O. Gotze, and B. P. Morgan. 1997. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia and endothelial cells in the inflamed human central nervous system. Am. J. Pathol. 150:31.
14. Stahel, P. F., T. Kossmann, M. C. Morganti-Kossmann, V. H. J. Hans, and S. R. Barnum. 1997. Experimental diffuse axonal injury induces enhanced neuronal C5a receptor mRNA expression in rats. Mol. Brain Res. 50:205.
15. Stahel, P. F., K. Frei, H. Eugster, A. Fontana, K. M. Hummel. R. A. Wetsel, R. S. Ames, and S. R. Barnum. 1997. TNF-α-mediated expression of the receptor for anaphylatoxin C5a on neurons in experimental Listeria meningoencephalitis. J. Immunol. 159:861.
16. Nataf, S., S. W. Levison, and S. R. Barnum, 2001. Expression of the anaphylatoxin C5aR in the oligodendrocyte lineage. Brain Res. 894:321.
17. O'Barr, S. A., J. Caguioa, D. Gruol, G. Perkins, J. A. Ember, T. E. Hugli, and N. R. Cooper. 2001. Neuronal expression of a functional receptor for the C5a complement activation fragment. J. Immunol. 166:4154.
18. Farkas, I., L. Baranyi, M. Takahashi, A. Fukuda, Zs. Liposits, T. Yamamoto, and H. Okada. 1998. A neuronal C5a receptor and an associated apoptotic signal transduction pathway. J. Physiol. 507:679.
19. Farkas, I., L. Baranyi, Y. Kaneko, Zs. Liposits, T. Yamamoto, and H. Okada. 1999. C5a receptor expression by TGW neuroblastoma cells. Neuroreport 10:3021.
20. Blalock, J. E. 1990. Complementarity of peptides specified by "sense" and "antisense" strands of DNA. Trends Biotechnol. 8:140.
21. Baranyi, L., W. Campbell, and H. Okada. 1995. The antisense homology box: a new motif within proteins that encodes biologically active peptides. Nat. Med. 1:894.
22. Baranyi, L., W. Campbell, and H. Okada. 1996. Antisense homology boxes in C5a receptor and C5a anaphylatoxin. J. Immunol. 157:4591.
23. Farkas, I., L. Baranyi, Zs. Liposits, T. Yamamoto, and H. Okada. 1998. Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells. Neuroscience 86:903.
24. Dobo, E., B. Dudas, I. Kallo, and Zs. Liposits. 1996. Novel immunohistochemical procedure for simultaneous detection of neuropeptide in human brain. Neurobiology 4:139.
25. Nakanishi, K., M. Nakanishi, and F. Kukita. 1999. Dual intracellular recording of neocortical neurons in a neuron-glia co-culture system. Brain Res. Protocols 4:105.
26. Yamamoto, N., K. Yoneda, K. Asai, K. Sobue, T. Tada, Y. Fujita, H. Katsuya, M. Fujita, N. Aihara, M. Mase, et al. 2001. Alterations in the expression of the AQP family in cultured rat astrocytes during hypoxia and reoxigenation. Mol. Brain Res. 90:26.
27. Fukuda, A., K. Muramatsu, A. Okabe, Y. Shimano, H. Hida, I. Fujimoto, and H. Nishino. 1998. NMDA receptor-mediated differential laminar susceptibility to the intracellular Ca accumulation induced by oxygen-glucose deprivation in rat neocortical slices. J. Neurophysiol. 79:430.
28. Braak, H., R. A. I. de Vos, E. N. H. Jansen, H. Bratzke, and E. Braak. 1998. Neuropathological hallmarks of Alzheimer's and Parkinson's diseases. Progr. Brain Res. 117:267.
29. Hyman, B. T., and T. Gomez-Isla. 1994. Alzheimer's disease is a laminar, regional and neural system specific disease, not a global brain disease. Neurobiol. Aging 15:353.
30. Nataf, S., N. Davoust, and S. R. Barnum. 1998. Kinetics of anaphylatoxin C5a receptor expression during experimental allergic encephalomyelitis. J. Neuroimmunol. 91:147.
31. Nataf, S., P. F. Stahel, N. Davoust, and S. R. Barnum. 1999. Complement anaphylatoxin receptors on neurons: new tricks for old receptors? Trends Neurosci. 22:397.
32. Stahel, P. F., K., Kariya, E. Shohami, S. R. Barnum, H. Eugster, O. Trentz, T. Kossmann, and M. C. Morganti-Kossmann. 2000. Intracerebral complement C5a-receptor (CD88) expression is regulated by TNF and lymphotoxin-α following closed head injury in mice. J. Neuroimmunol. 109:164.
33. VanBeek, J., M. Bernaudin, E. Petit, P. Gasque, A. Nouvelot, E. T. MacKenzie, and M. Fontaine. 2000. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse. Exp. Neurol. 161:373.
34. Guo, R. F., M. Huber-Lang, X. Wang, V. Sarma, V. A. Padgaonkar, R. A. Craig, N. C. Riedemann, S. D. McClintock, T. Hlaing, M. M. Shi, and P. A. Ward. 2000. Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis. J. Clin. Invest. 106:1271.
35. Czermak, B. J., V. Sarma, C. L. Pierson, R. L. Warner, M. Huber-Lang, N. M. Bless, H. Schmal, H. P. Friedl, and P. A. Ward. 1999. Protective effects of C5a blockade in sepsis. Nat. Med. 5:788.
36. Huber-Lang, M., V. Sarma, K. T. Lu, S. R. McGuire, V. A. Padgaonkar, R. F. Guo, E. M. Younkin, R. G. Kunkel, J. Ding, R. Erickson, et al. 2001. Role of C5a in multiorgan failure during sepsis. J. Immunol. 166:1193.
37. Mukherjee, P., and G. M. Pasinetti. 2000. The role of complement anaphylatoxin C5a in neurodegeneration: implications in Alzheimer's disease. J. Neuroimmunol. 105:124.
38. Osaka, H., P. Mukherjee, P. S. Aisen, and G. M. Pasinetti. 1999. Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity. J. Cell. Biochem. 73:303.
39. Pasinetti, G. M. 1996. Inflammatory mechanisms in neurodegeneration and Alzheimer's disease, the role of the complement system. Neurobiol. Aging 17:707.
40. Konteatis, Z. D., S. J. Siciliano, G. Van Riper, C. J. Molineaux, S. Pandya, P. Fischer, H. Rosen, R. A. Mumford, and M. S. Springer. 1994. Development of C5a receptor antagonists. J. Immunol. 153:4200.
41. Riedemann, N. C., T. A. Neff, R. F. Guo, K. D. Bernacki, I. J. Laudes, V. Sarma, J. D. Lambris, and P. A. Ward. 2003. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J. Immunol. 170:503.
42. Riedemann, N. C., R. F. Guo, I. J. Laudes, K. Keller, V. Sarma, V. A. Padgaonkar, F. S. Zetoune, and P. A. Ward. 2002. C5a receptor and thymocyte apoptosis in sepsis. FASEB J. 10:1096.
43. Lotem, J., and L. Sachs. 1996. Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents. Proc. Natl. Acad. Sci. USA 93:12507.